Viatris Inc
VTRS11.930USD
-0.010-0.08%
Handelsschluss 12/19, 16:00（ET）Kurse um 15 Minuten verzögert
13.83BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Viatris Inc Unternehmen
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. It produces oral solid doses, injectables, and products with complex dosage forms.
Viatris Inc Informationen
BörsenkürzelVTRS
Name des UnternehmensViatris Inc
IPO-datumFeb 01, 1973
CEOSmith (Scott A)
Anzahl der mitarbeiter32000
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 01
Addresse1000 Mylan Boulevard
StadtCANONSBURG
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl15317
Telefon17245141465
Websitehttps://www.viatris.com/en
BörsenkürzelVTRS
IPO-datumFeb 01, 1973
CEOSmith (Scott A)
Führungskräfte von Viatris Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Rajiv Malik
Mr. Rajiv Malik
Director
Director
1.07M
--
Mr. Paul B. Campbell
Mr. Paul B. Campbell
Chief Accounting Officer, Corporate Controller
Chief Accounting Officer, Corporate Controller
254.46K
--
Mr. Brian Roman
Mr. Brian Roman
Chief Legal Officer
Chief Legal Officer
193.92K
--
Mr. Richard A. Mark, CPA
Mr. Richard A. Mark, CPA
Independent Director
Independent Director
91.31K
--
Mr. Wyllie Don Cornwell
Mr. Wyllie Don Cornwell
Independent Director
Independent Director
80.34K
--
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
37.83K
--
Ms. Theodora (Doretta) Mistras
Ms. Theodora (Doretta) Mistras
Chief Financial Officer
Chief Financial Officer
25.18K
--
Ms. JoEllen Lyons Dillon
Ms. JoEllen Lyons Dillon
Independent Director
Independent Director
--
--
Mr. Mark W. Parrish
Mr. Mark W. Parrish
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Melina E. Higgins
Ms. Melina E. Higgins
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Rajiv Malik
Mr. Rajiv Malik
Director
Director
1.07M
--
Mr. Paul B. Campbell
Mr. Paul B. Campbell
Chief Accounting Officer, Corporate Controller
Chief Accounting Officer, Corporate Controller
254.46K
--
Mr. Brian Roman
Mr. Brian Roman
Chief Legal Officer
Chief Legal Officer
193.92K
--
Mr. Richard A. Mark, CPA
Mr. Richard A. Mark, CPA
Independent Director
Independent Director
91.31K
--
Mr. Wyllie Don Cornwell
Mr. Wyllie Don Cornwell
Independent Director
Independent Director
80.34K
--
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
37.83K
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Brands
2.28B
64.01%
Generics
1.28B
35.99%
Nach RegionUSD
Name
Umsatz
Anteil
Developed markets
2.12B
59.38%
Greater China
588.90M
16.50%
Emerging Markets
555.10M
15.55%
JANZ
305.70M
8.57%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Brands
2.28B
64.01%
Generics
1.28B
35.99%
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.14%
T. Rowe Price Associates, Inc.
7.13%
Davis Selected Advisers, L.P.
6.02%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.84%
Andere
64.56%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.14%
T. Rowe Price Associates, Inc.
7.13%
Davis Selected Advisers, L.P.
6.02%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.84%
Andere
64.56%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
44.04%
Investment Advisor/Hedge Fund
28.24%
Hedge Fund
8.77%
Research Firm
2.71%
Pension Fund
1.29%
Sovereign Wealth Fund
1.01%
Bank and Trust
0.85%
Individual Investor
0.27%
Family Office
0.06%
Andere
12.75%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
1934
987.12M
85.35%
-46.41M
2025Q2
1947
984.91M
83.97%
-87.31M
2025Q1
2006
1.01B
85.93%
-61.76M
2024Q4
2002
1.03B
86.53%
+1.20M
2024Q3
1949
989.28M
82.89%
-66.19M
2024Q2
1967
1.02B
85.33%
-16.59M
2024Q1
1986
997.86M
84.00%
-35.39M
2023Q4
2032
990.53M
82.57%
-31.15M
2023Q3
2044
970.48M
80.90%
-45.34M
2023Q2
2080
963.51M
80.35%
-35.04M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
144.70M
12.41%
+694.66K
+0.48%
Jun 30, 2025
T. Rowe Price Associates, Inc.
76.96M
6.6%
+4.28M
+5.89%
Jun 30, 2025
Davis Selected Advisers, L.P.
66.38M
5.69%
+1.43M
+2.20%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
61.38M
5.26%
-2.94M
-4.57%
Jun 30, 2025
State Street Investment Management (US)
55.29M
4.74%
-6.17M
-10.04%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
31.26M
2.68%
+10.00M
+47.05%
Jun 30, 2025
Geode Capital Management, L.L.C.
31.23M
2.68%
+52.78K
+0.17%
Jun 30, 2025
Columbia Threadneedle Investments (US)
22.77M
1.95%
+1.16M
+5.38%
Jun 30, 2025
Deerfield Management Company, L.P.
24.02M
2.06%
+32.31K
+0.13%
Jun 30, 2025
Invesco Capital Management LLC
24.15M
2.07%
+928.68K
+4.00%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares U.S. Pharmaceuticals ETF
4.46%
First Trust NASDAQ Pharmaceuticals ETF
3.81%
Davis Select Worldwide ETF
3.62%
Davis Select US Equity ETF
3.36%
Invesco Pharmaceuticals ETF
2.66%
State Street SPDR S&P Pharmaceuticals ETF
2.64%
Invesco S&P Ultra Dividend Revenue ETF
2.56%
Alps Sector Dividend Dogs ETF
2.1%
AAM S&P 500 High Dividend Value ETF
1.95%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.88%
Mehr Anzeigen
iShares U.S. Pharmaceuticals ETF
Anteil4.46%
First Trust NASDAQ Pharmaceuticals ETF
Anteil3.81%
Davis Select Worldwide ETF
Anteil3.62%
Davis Select US Equity ETF
Anteil3.36%
Invesco Pharmaceuticals ETF
Anteil2.66%
State Street SPDR S&P Pharmaceuticals ETF
Anteil2.64%
Invesco S&P Ultra Dividend Revenue ETF
Anteil2.56%
Alps Sector Dividend Dogs ETF
Anteil2.1%
AAM S&P 500 High Dividend Value ETF
Anteil1.95%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Anteil1.88%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
2.13B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 04, 2025
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 15, 2025 going ex on Nov 24, 2025
Nov 24, 2025
Dec 15, 2025
Nov 24, 2025
Aug 05, 2025
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 15, 2025 going ex on Aug 22, 2025
Aug 22, 2025
Sep 15, 2025
Aug 22, 2025
May 07, 2025
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 16, 2025 going ex on May 23, 2025
May 23, 2025
Jun 16, 2025
May 23, 2025
Feb 27, 2025
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 18, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 18, 2025
Mar 10, 2025
Nov 05, 2024
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 13, 2024 going ex on Nov 22, 2024
Nov 22, 2024
Dec 13, 2024
Nov 22, 2024
Aug 06, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 13, 2024 going ex on Aug 23, 2024
Aug 23, 2024
Sep 13, 2024
Aug 23, 2024
May 09, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 14, 2024 going ex on May 23, 2024
May 24, 2024
Jun 14, 2024
May 23, 2024
Feb 28, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 18, 2024 going ex on Mar 08, 2024
Mar 11, 2024
Mar 18, 2024
Mar 08, 2024
Nov 08, 2023
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 15, 2023 going ex on Nov 22, 2023
Nov 24, 2023
Dec 15, 2023
Nov 22, 2023
Aug 07, 2023
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 15, 2023 going ex on Aug 23, 2023
Aug 24, 2023
Sep 15, 2023
Aug 23, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Viatris Inc?
Die fünf größten Anteilseigner von Viatris Inc sind:
The Vanguard Group, Inc. hält 144.70M Aktien, was 12.41% der Gesamtaktien entspricht.
T. Rowe Price Associates, Inc. hält 76.96M Aktien, was 6.60% der Gesamtaktien entspricht.
Davis Selected Advisers, L.P. hält 66.38M Aktien, was 5.69% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 61.38M Aktien, was 5.26% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 55.29M Aktien, was 4.74% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 144.70M Aktien, was 12.41% der Gesamtaktien entspricht.
T. Rowe Price Associates, Inc. hält 76.96M Aktien, was 6.60% der Gesamtaktien entspricht.
Davis Selected Advisers, L.P. hält 66.38M Aktien, was 5.69% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 61.38M Aktien, was 5.26% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 55.29M Aktien, was 4.74% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Viatris Inc?
Die drei wichtigsten Anteilseigner-Typen von Viatris Inc sind:
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
Davis Selected Advisers, L.P.
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
Davis Selected Advisers, L.P.
Wie viele Institutionen halten Anteile an Viatris Inc (VTRS)?
Mit Stand vom 2025Q3 halten 1934 Institutionen Anteile an Viatris Inc, mit einem Gesamtmarktwert von etwa 987.12M, was 85.35% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um 1.37% gestiegen.
Was ist die größte Einnahmequelle von Viatris Inc?
Am FY2025Q2 erzielte das Geschäft mit Brands für Viatris Inc den höchsten Umsatz in Höhe von 2.28B, was 64.01% des Gesamtumsatzes entspricht.
